3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Esophageal Neoplasms
1
Interventions
pembrolizumab
379
Carboplatin
279
Specimen Handling
266
Nivolumab
256
Magnetic Resonance Spectroscopy
245
Cyclophosphamide
242
Cisplatin
217
Paclitaxel
207
Radiotherapy
196
Biopsy
171
Gemcitabine
158
Dexamethasone
149
durvalumab
147
atezolizumab
128
Rituximab
123
Doxorubicin
117
Bevacizumab
115
Ipilimumab
114
Lenalidomide
113
Radiation
111
Pemetrexed
104
Docetaxel
104
Etoposide
102
fludarabine
97
venetoclax
96
Capecitabine
94
Radiosurgery
93
Fluorouracil
93
Oxaliplatin
91
Prednisone
90
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Chemoradiotherapy, Adjuvant
×
1 year
×
Clear all
NCT05667298
2026-05-11
OPERARADIO
University of Manitoba
Phase 1
Active not recruiting
11 enrolled